188 related articles for article (PubMed ID: 4179565)
1. Cyclophosphamide vs melphalan in treatment of plasma cell myeloma.
Rivers SL; Patno ME
JAMA; 1969 Feb; 207(7):1328-34. PubMed ID: 4179565
[No Abstract] [Full Text] [Related]
2. Treatment of myelomatosis--M.R.C. trial.
Galton DA
Br Med J; 1971 May; 2(5757):323-4. PubMed ID: 4930211
[No Abstract] [Full Text] [Related]
3. Plasmacytic myeloma. A study of the relationship of survival to various clinical manifestations and anomalous protein type in 112 patients.
Carbone PP; Kellerhouse LE; Gehan EA
Am J Med; 1967 Jun; 42(6):937-48. PubMed ID: 6027163
[No Abstract] [Full Text] [Related]
4. Growth rates and responses to treatment in human myelomatosis.
Hobbs JR
Br J Haematol; 1969 Jun; 16(6):607-17. PubMed ID: 4184691
[No Abstract] [Full Text] [Related]
5. Plasma cell myeloma with D-myeloma protein (IgD myeloma).
Fahey JL; Carbone PP; Rowe DS; Bachmann R
Am J Med; 1968 Sep; 45(3):373-80. PubMed ID: 4175067
[No Abstract] [Full Text] [Related]
6. [Benign and malignant monoclonal hypergammaglobulinemia (gammopathy)].
Waldenström J
Schweiz Med Wochenschr; 1970 Feb; 100(7):290-6. PubMed ID: 4189916
[No Abstract] [Full Text] [Related]
7. [Comparative study of the melphalan and of the cyclophosphamide in the treatment of Kahler's disease].
Bontoux D; Chenbit D; Delbarre F
Therapeutique; 1971 Jan; 47(1):27-32. PubMed ID: 5572915
[No Abstract] [Full Text] [Related]
8. Immunocytoma o' mice an' men.
Hobbs JR
Br Med J; 1971 Apr; 2(5753):67-72. PubMed ID: 4101482
[No Abstract] [Full Text] [Related]
9. A urinary cryo-Bence Jones protein gelling at room temperature.
Harris RI; Kohn J
Clin Chim Acta; 1974 Jun; 53(2):233-7. PubMed ID: 4841989
[No Abstract] [Full Text] [Related]
10. Plasma cell myeloma: response of melphalan-resistant patients to high-dose intermittent cyclophosphamide.
Bergsagel DE; Cowan DH; Hasselback R
Can Med Assoc J; 1972 Nov; 107(9):851-5. PubMed ID: 4653931
[TBL] [Abstract][Full Text] [Related]
11. Melphalan in multiple myeloma.
Hoogstraten B; Sheehe PR; Cuttner J; Cooper T; Kyle RA; Oberfield RA; Townsend SR; Harley JB; Hayes DM; Costa G; Holland JF
Blood; 1967 Jul; 30(1):74-83. PubMed ID: 6028709
[No Abstract] [Full Text] [Related]
12. Melphalan therapy for plasma cell myeloma.
Alexanian R; Bergsagel DE; Migliore PJ; Vaughn WK; Howe CD
Blood; 1968 Jan; 31(1):1-10. PubMed ID: 5638562
[No Abstract] [Full Text] [Related]
13. Multiple myeloma without initial paraproteins.
Kim I; Harley JB; Weksler B
Am J Med Sci; 1972 Oct; 264(4):267-75. PubMed ID: 4630526
[No Abstract] [Full Text] [Related]
14. Cyclophosphamide in the treatment of myelomatosis.
Choi OS; English A; Hilton JH; Catton GE; Brown MD
Can Med Assoc J; 1967 Nov; 97(19):1133-9. PubMed ID: 4168247
[No Abstract] [Full Text] [Related]
15. Treatment of multiple myeloma.
Brodsky I; Kahn SB; Meyer AN
Geriatrics; 1967 Mar; 22(3):140-8. PubMed ID: 6019488
[No Abstract] [Full Text] [Related]
16. [Clinical importance of paraprotein of the type kappa and lambda in Bence-Jones myeloma].
Iavorskiĭ LI; Andreeva NE; Antipova LG; Riauzova LN
Probl Gematol Pereliv Krovi; 1979 Jun; 24(6):3-9. PubMed ID: 111238
[No Abstract] [Full Text] [Related]
17. [Treatment of myeloma].
Le Chevallier PL
Sem Hop; 1971 Jan; 47(4):249-51. PubMed ID: 4322132
[No Abstract] [Full Text] [Related]
18. Plasma cell leukemia with IgD paraprotein.
Ben-Bassat I; Frand UI; Isersky C; Ramot B
Arch Intern Med; 1968 Apr; 121(4):361-4. PubMed ID: 4171442
[No Abstract] [Full Text] [Related]
19. [Myeloma : symptoms, diagnosis, treatment].
Piguet H; Borg JY; Monconduit M; Bizet M
Rev Prat; 1979 Jan; 29(3):333-6, 339-44, 347-8. PubMed ID: 419356
[No Abstract] [Full Text] [Related]
20. Management of multiple myeloma.
Malpas JS
Br Med J; 1969 Apr; 2(5650):163-5. PubMed ID: 5778941
[No Abstract] [Full Text] [Related]
[Next] [New Search]
